Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -42.11% is 43% below its 5-year average of -29.38%, near the low end of its 5-year range (-42.11%–-20.19%).
As of the fiscal period ended Tuesday, June 30, 2026. 26.29% below its 12-month average of -33.34%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -42.11%.
RETURN ON INVESTED CAPITAL (ROIC)
-42.11%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-33.34%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-30.82%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-29.38%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
-26.29%
CURRENT VS 3Y AVG
-36.61%
CURRENT VS 5Y AVG
-43.33%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-35.64%
median of 838 covered companies
CURRENT VS SECTOR MEDIAN
-18.13%
vs the sector median at left
Nkarta, Inc.
Market Cap
$165.27M
Return on Invested Capital (ROIC)
-42.11%
TTM Avg
-33.34%
3Y Avg
-30.82%
5Y Avg
-29.38%
Market Cap
$165.88M
Return on Invested Capital (ROIC)
4.92%
TTM Avg
-1.65%
3Y Avg
-7.20%
5Y Avg
-5.46%
Market Cap
$166.54M
Return on Invested Capital (ROIC)
-1039.56%
TTM Avg
-137.05%
3Y Avg
-111.74%
5Y Avg
-93.55%
Market Cap
$162.28M
Return on Invested Capital (ROIC)
-49.08%
TTM Avg
-23.18%
3Y Avg
-21.02%
5Y Avg
-18.22%
Market Cap
$162.23M
Return on Invested Capital (ROIC)
-135.38%
TTM Avg
-110.80%
3Y Avg
-91.23%
5Y Avg
-65.73%
Market Cap
$168.86M
Return on Invested Capital (ROIC)
-58.55%
TTM Avg
-41.33%
3Y Avg
-32.67%
5Y Avg
-48.97%
Market Cap
$169.32M
Return on Invested Capital (ROIC)
-8.34%
TTM Avg
4.10%
3Y Avg
3.63%
5Y Avg
7.54%
Market Cap
$160.65M
Return on Invested Capital (ROIC)
-38.56%
TTM Avg
-39.74%
3Y Avg
-42.41%
5Y Avg
-37.88%
Market Cap
$159.44M
Return on Invested Capital (ROIC)
-57.59%
TTM Avg
-65.44%
3Y Avg
-58.20%
5Y Avg
-45.38%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Nkarta, Inc. (NKTX) | $165.27M | -42.11% | -33.34% | -30.82% | -29.38% |
| OptimizeRx Corp. (OPRX)vs › | $165.88M | 4.92% | -1.65% | -7.20% | -5.46% |
| Cue Biopharma, Inc. (CUE)vs › | $166.54M | -1039.56% | -137.05% | -111.74% | -93.55% |
| Quanterix Corporation (QTRX)vs › | $162.28M | -49.08% | -23.18% | -21.02% | -18.22% |
| Coherus Oncology, Inc. (CHRS)vs › | $162.23M | -135.38% | -110.80% | -91.23% | -65.73% |
| MediWound Ltd. (MDWD)vs › | $168.86M | -58.55% | -41.33% | -32.67% | -48.97% |
| Organogenesis Holdings Inc. (ORGO)vs › | $169.32M | -8.34% | 4.10% | 3.63% | 7.54% |
| Minerva Neurosciences, Inc. (NERV)vs › | $160.65M | -38.56% | -39.74% | -42.41% | -37.88% |
| PepGen Inc. (PEPG)vs › | $159.44M | -57.59% | -65.44% | -58.20% | -45.38% |
| LifeMD, Inc. (LFMDP)vs › | $159.22M | -143.97% | -52.39% | -55.03% | -91.26% |
ROIC
-42.1%
ROE
-47.4%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -42.11% |
| 2026-03-31 | -32.87% |
| 2025-12-31 | -31.94% |
| 2025-09-30 | -29.87% |
| 2025-06-30 | -29.92% |
| 2025-03-31 | -29.21% |
| 2024-12-31 | -26.58% |
| 2024-09-30 | -25.21% |
| 2024-06-30 | -23.25% |
| 2024-03-31 | -23.20% |
| 2023-12-31 | -37.03% |
| 2023-09-30 | -35.62% |
| 2023-06-30 | -33.90% |
| 2023-03-31 | -29.42% |
| 2022-12-31 | -26.14% |
| 2022-09-30 | -22.38% |
| 2022-06-30 | -20.19% |
| 2022-03-31 | -31.49% |
| 2021-12-31 | -33.12% |
| 2021-09-30 | -29.08% |
| 2021-06-30 | -24.38% |
| 2021-03-31 | -19.47% |
| 2020-12-31 | -15.66% |
| 2020-09-30 | -12.30% |
| 2020-03-31 | -85.82% |
| 2019-12-31 | -53.57% |
